Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,895 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[AUTOTRANSPLANTATION FOR IATROGENIC URETERAL INJURY FOLLOWING GYNECOLOGICAL SURGERY].
Kinoshita A, Yamada D, Honda K, Danno T, Tokunaga M, Miyakawa J, Taguchi S, Akiyama Y, Yamada Y, Sato Y, Kume H. Kinoshita A, et al. Among authors: yamada y, yamada d. Nihon Hinyokika Gakkai Zasshi. 2022;113(4):147-151. doi: 10.5980/jpnjurol.113.147. Nihon Hinyokika Gakkai Zasshi. 2022. PMID: 37866936 Free article. Japanese.
Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.
Fujimura T, Takahashi S, Urano T, Takayama K, Sugihara T, Obinata D, Yamada Y, Kumagai J, Kume H, Ouchi Y, Inoue S, Homma Y. Fujimura T, et al. Among authors: yamada y. Clin Cancer Res. 2014 Sep 1;20(17):4625-35. doi: 10.1158/1078-0432.CCR-13-1105. Epub 2014 Jul 1. Clin Cancer Res. 2014. PMID: 24987058
Nocturia in men is a chaotic condition dominated by nocturnal polyuria.
Fujimura T, Yamada Y, Sugihara T, Azuma T, Suzuki M, Fukuhara H, Nakagawa T, Kume H, Igawa Y, Homma Y. Fujimura T, et al. Among authors: yamada y. Int J Urol. 2015 May;22(5):496-501. doi: 10.1111/iju.12710. Epub 2015 Jan 29. Int J Urol. 2015. PMID: 25631284
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial.
Fujimura T, Takahashi S, Kume H, Urano T, Takayama K, Yamada Y, Suzuki M, Fukuhara H, Nakagawa T, Inoue S, Homma Y. Fujimura T, et al. Among authors: yamada y. BMC Cancer. 2015 Nov 2;15:836. doi: 10.1186/s12885-015-1871-z. BMC Cancer. 2015. PMID: 26526623 Free PMC article. Clinical Trial.
9,895 results